abstract |
the present invention relates to innovative compounds that inhibit lrrk2 kinase activity, processes for their preparation, compositions containing them and their use in the treatment or prevention of diseases associated or characterized by the activity of lrrk2 kinase, for example parkinson's, alzheimer's disease or amyotrophic lateral sclerosis (als). |